KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) Gross Margin (2017 - 2025)

Elanco Animal Health's Gross Margin history spans 9 years, with the latest figure at 51.49% for Q4 2025.

  • For Q4 2025, Gross Margin rose 60.0% year-over-year to 51.49%; the TTM value through Dec 2025 reached 54.99%, up 12.0%, while the annual FY2025 figure was 54.99%, 12.0% up from the prior year.
  • Gross Margin for Q4 2025 was 51.49% at Elanco Animal Health, down from 53.39% in the prior quarter.
  • Across five years, Gross Margin topped out at 60.7% in Q1 2023 and bottomed at 50.14% in Q4 2023.
  • The 5-year median for Gross Margin is 55.07% (2022), against an average of 55.45%.
  • The largest annual shift saw Gross Margin skyrocketed 740bps in 2021 before it tumbled -437bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 54.14% in 2021, then grew by 1bps to 54.52% in 2022, then decreased by -8bps to 50.14% in 2023, then increased by 1bps to 50.88% in 2024, then grew by 1bps to 51.49% in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Gross Margin are 51.49% (Q4 2025), 53.39% (Q3 2025), and 57.45% (Q2 2025).